-
公开(公告)号:US20130303807A1
公开(公告)日:2013-11-14
申请号:US13939834
申请日:2013-07-11
Applicant: Neonc Technologies, Inc.
Inventor: Thomas CHEN , DANIEL LEVIN , SATISH PUPPALI
IPC: C07C29/78
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07C2601/16 , C07C33/14 , C07C205/57 , C07C69/76 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
-
公开(公告)号:US20150368173A1
公开(公告)日:2015-12-24
申请号:US14817286
申请日:2015-08-04
Applicant: NEONC Technologies, Inc.
Inventor: Thomas CHEN , DANIEL LEVIN , SATISH PUPPALI
IPC: C07C29/88 , C07C201/12 , C07C67/14 , C07C201/16
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07C2601/16 , C07C33/14 , C07C205/57 , C07C69/76 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
Abstract translation: 本发明提供纯化大于约98.5%(w / w)的单萜或倍半萜的方法。 该方法包括衍生单萜(或倍半萜烯)以产生单萜(或倍半萜烯)衍生物,分离单萜(或倍半萜烯)衍生物和从衍生物中释放单萜(或倍半萜烯)的步骤。 包括本发明范围的药物组合物是包含纯度大于约98.5%(w / w)的单萜(或倍半萜烯)的药物组合物。 纯化的单萜可用于治疗癌症等疾病。 本单萜(或倍半萜烯)可以单独施用,或者可以与辐射或其它治疗剂如化学治疗剂共同施用。
-
公开(公告)号:US20160158162A1
公开(公告)日:2016-06-09
申请号:US15040002
申请日:2016-02-10
Applicant: NEONC Technologies, Inc.
Inventor: Thomas CHEN , DANIEL LEVIN , SATISH PUPPALI
IPC: A61K31/045 , A61N5/10 , A61K45/06 , A61K31/4188
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07C2601/16 , C07C33/14 , C07C205/57 , C07C69/76 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
-
公开(公告)号:US20160039730A1
公开(公告)日:2016-02-11
申请号:US14843097
申请日:2015-09-02
Applicant: NEONC Technologies, Inc.
Inventor: Thomas CHEN , DANIEL LEVIN , SATISH PUPPALI
CPC classification number: C07C29/92 , A61K31/045 , A61K31/4188 , A61K45/06 , A61N5/10 , C07B2200/07 , C07C29/78 , C07C29/86 , C07C29/88 , C07C67/14 , C07C201/12 , C07C201/16 , C07C2601/16 , C07C33/14 , C07C205/57 , C07C69/76 , C07C69/92
Abstract: The present invention provides a process for purifying a monoterpene or sesquiterpene having a purity greater than about 98.5% (w/w). The process comprises the steps of derivatizing the monoterpene (or sesquiterpene) to produce a monoterpene (or sesquiterpene) derivative, separating the monoterpene (or sesquiterpene) derivative, and releasing the monoterpene (or sesquiterpene) from the derivative. Also encompassed by the scope of the present invention is a pharmaceutical composition comprising a monoterpene (or sesquiterpene) having a purity greater than about 98.5% (w/w). The purified monoterpene can be used to treat a disease such as cancer. The present monoterpene (or sesquiterpene) may be administered alone, or may be co-administered with radiation or other therapeutic agents, such as chemotherapeutic agents.
-
-
-